Document is current
Any future updates will be listed below
-
Authors
Flanagan, Kevin C https://orcid.org/0009-0005-3364-1677
Earls, Jon
Hiken, Jeffrey
Wellinghoff, Rachel L
Ponder, Michelle M
McLeod, Howard L
Westra, William H
Vavinskaya, Vera
Sutton, Leisa
Deichaite, Ida
Macdonald, Orlan K
Welaya, Karim
Wade, James III
Azzi, Georges
Pippas, Andrew W
Slim, Jennifer
Bank, Bruce
Sui, Xingwei
Kossman, Steven E
Shenkenberg, Todd D
Alexander, Warren L
Price, Katharine A
Ley, Jessica
Messina, David N
Glasscock, Jarret I
Colevas, A Dimitrios
Cohen, Ezra E W
Adkins, Douglas
Duncavage, Eric J
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04510129 at ClinicalTrials.govnct04510129 at ClinicalTrials.govDocuments that mention this clinical trial
Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study
https://doi.org/10.1136/jitc-2024-009573
Documents that mention this clinical trial
Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study
https://doi.org/10.1136/jitc-2024-009573
-
Funding
Funding for this research was provided by:
Cofactor Genomics, Inc
- License Information
